IND-Enabling Studies
The specific set of preclinical studies required by regulatory agencies to support an Investigational New Drug application and initiate first-in-human clinical trials. Includes GLP toxicology (acute and repeat-dose), genotoxicity, safety pharmacology (cardiovascular, respiratory, CNS), PK/ADME characterization, and chemistry/manufacturing/controls (CMC) documentation. Typically takes 12-18 months and costs $2-5 million.
Examples
- 14-day GLP toxicology study in two species
- hERG channel assay for QT prolongation risk
- Ames test and in vivo micronucleus for genotoxicity
Did You Know?
The specific set of preclinical studies required by regulatory agencies to support an Investigational New Drug application and initiate first-in-human clinical trials. Includes GLP toxicology (acute and repeat-dose), genotoxicity, safety …